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Abstract
In contrast to women with relatively asymptomatic endometriosis, women with endometriosis-
associated chronic pelvic pain (CPP) exhibit non-pelvic hyperalgesia and decreased gray matter 
volume in key neural pain processing regions. While these findings suggest central pain 
amplification in endometriosis-associated CPP, the underlying changes in brain chemistry and 
function associated with central pain amplification remain unknown. We performed proton 
spectroscopy and seed-based resting functional connectivity MRI to determine whether women 
with endometriosis display differences in insula excitatory neurotransmitter concentrations or 
intrinsic brain connectivity to other pain-related brain regions. Relative to age-matched pain-free 
controls, women with endometriosis-associated CPP displayed elevated levels of combined 
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glutamine-glutamate (Glx) within the anterior insula, and greater anterior insula connectivity to 
the medial prefrontal cortex (mPFC). Increased connectivity between these regions was positively 
correlated with anterior insula Glx concentrations (r=0.87), as well as clinical anxiety 
(r=0.61,p=0.02), depression (r=0.60,p=0.03), and pain intensity (r=0.55,p=0.05). There were no 
significant differences in insula metabolite levels or resting-state connectivity in endometriosis 
without CPP subjects versus controls. We conclude that enhanced anterior insula glutamatergic 
neurotransmission and connectivity with the mPFC, key regions of the salience and default mode 
networks, may play a role in the pathophysiology of CPP independent of the presence of 
endometriosis.
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Introduction
Endometriosis is a common gynecologic condition estimated to affect 10–15% of 
reproductive-aged women and up to 80% of women with chronic pelvic pain 
(CPP).21, 43, 45, 62, 68 Endometriosis is defined as the presence of endometrial glands and 
stroma (referred to as “endometriosis implants”) outside of the uterus. Thus it is a 
histological diagnosis that requires surgical evaluation and biopsy. Although endometriosis 
is the most common finding among women undergoing surgery for CPP and likely 
contributes to pain in at least some of these women, it is unclear whether endometriosis is 
the underlying cause of pelvic pain in all of these women. Little is known about the 
mechanisms involved in the development of chronic pain in this population. As with most 
chronic pain syndromes, the presence and severity of organic pathology do not correlate 
with symptom severity and many women with endometriosis, even severe, experience little 
if any pain.7, 38, 54, 67 Furthermore, standard therapies targeting endometriosis implants are 
not consistently effective and pain frequently recurs, often without evidence of residual 
pelvic pathology.57, 61, 66 Against this background, endometriosis must be viewed as an 
important but insufficient factor in the development of CPP.
Central nervous system (CNS) abnormalities in pain processing have been identified in 
multiple chronic pain syndromes, which often occur in the absence of identifiable pathology 
in the area of pain. Findings include hyperalgesia within and outside of areas of clinical 
pain, parallel increases in neural activity, as well as structural alterations in pain-related 
cortical areas.16, 28, 31, 47, 56 More recently, aberrant brain neurochemistry and functional 
connectivity have also been identified in patients with other chronic pain conditions. The 
insula, a brain region involved the integration of interoceptive, affective and cognitive 
signals, is a primary focus in pain neuroimaging studies as it is one of the most consistently 
activated regions during acute and chronic pain.3 For example, increased levels of excitatory 
neurotransmitters within the posterior insula and decreased levels of inhibitory 
neurotransmitters within the anterior insula have been identified in patients with 
fibromyalgia.25, 33 Furthermore, resting state brain connectivity of the insula is augmented 
in neural pain processing regions of fibromyalgia patients relative to pain-free controls.39, 52 
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These neural signals likely play a role in the underlying pathophysiology of chronic pain and 
may also have utility in clinical medicine since they are correlated with important patient-
centered outcomes, such as clinical pain intensity and response to pharmacotherapy used to 
treat chronic pain.32, 51
Our group has previously demonstrated that women with CPP, both with and without 
endometriosis, also exhibit hyperalgesia in a non-pelvic site as well as decreases in regional 
gray matter volume in brain regions associated with pain processing including the thalamus, 
cingulate gyrus, putamen and insula, suggesting a similar problem of pain amplification 
related to CNS changes.5, 6 While various neural mechanisms contributing to pain 
amplification have been identified in other pain syndromes, the precise nature of these 
neural changes remain unknown in women with endometriosis-associated pelvic pain. 
Identifying specific neural mechanisms associated with pain amplification are necessary to 
develop targeted treatment strategies for women who are not responsive to traditional 
medical and surgical therapies for endometriosis and other causes of CPP.
The primary objective of this study was to use proton spectroscopy (1H-MRS) and 
functional connectivity MRI techniques to determine whether women with endometriosis-
associated CPP display changes in excitatory neurotransmitters concentrations in the insula 
and/or changes in intrinsic brain connectivity between the insula and other pain-related brain 
structures. To investigate whether such neuroimaging changes are related to endometriosis 
versus the presence of CPP, we also investigated women with similar pelvic pathology 
(endometriosis) but without CPP. As previously demonstrated in other chronic pain 
conditions, we hypothesized that endometriosis-associated CPP is associated with elevated 
levels of excitatory neurotransmitters in the insula and increased intrinsic brain connectivity 
of the insula to other brain regions associated with pain perception and modulation, and that 
these findings would not be identified in endometriosis subjects without CPP.
Material and Methods
Study population and case definitions
The following subgroups of patient participants were included in this cross-sectional 
observational neuroimaging study: 17 women with endometriosis-associated CPP 
(⊕Endo⊕CPP)and 13 women with endometriosis without chronic pelvic pain 
(⊕EndoØCPP). For exploratory purposes, an additional group of 6 women with CPP but no 
evidence of endometriosis (ØEndo⊕CPP) was also evaluated. Participants in this study were 
included in a previously published study of regional cerebral gray matter differences in 
women with chronic pelvic pain.6 All participants were premenopausal women aged 18–52 
years who had not undergone prior hysterectomy or bilateral oophorectomy. Women with 
endometriosis were recruited from a tertiary-care endometriosis and pelvic pain referral 
center, as well as through advertisement to the local community.
A pool of twenty-four pain-free healthy controls was recruited from ongoing studies using 
the same functional MRI protocol used in this study (mean age ± SD: 29.3 ± 10.1 years). 
Controls were recruited through local advertisement. Because brain imaging parameters 
change with age and age varied significantly across patient subgroups, a subset of healthy 
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controls was randomly chosen ratio from pool of 24 healthy control sample to match the age 
distribution of the patient subgroups (14 controls were available for the ⊕Endo⊕CPP, and 
12 controls were available for the ⊕EndoØCPP). Due to the small sample size in the 
exploratory ØEndo⊕CPP group (n=6), 11 controls were randomly selected to match the age-
distribution of this group. This design was used, similar to previously published methods6, 
because we were unable to directly compare brain imaging findings of ⊕Endo⊕CPP 
subjects (mean ± SD age, 26.1 ± 6.3 years) to ⊕EndoØCPP subjects (mean ± SD age, 36.6 ± 
8.7 years) due to the significant 10 year age difference between these two groups.
Potential participants with a history of endometriosis were screened by a phone interview 
and were invited to participate only if they met criteria for either (1) endometriosis with 
chronic pelvic pain (⊕Endo⊕CPP) or (2) endometriosis without chronic pelvic pain 
(⊕EndoØCPP). All endometriosis participants were required to have a history of surgically 
confirmed endometriosis within 3 years of study participation. CPP was defined as moderate 
to severe pelvic pain rated as ≥ 4 on a 0–10 numeric rating scale, pelvic pain was present for 
greater than 6 months duration, and was non-cyclic occurring for at least 14 days of each 
month, not just limited to the time of menstrual bleeding. All numeric pain scales in this 
study defined the value “0” as “no pain” and “10” as “pain as bad as you can imagine”.35 
Pelvic pain had to be localized to the anatomic pelvis, and was not exclusively limited to 
symptoms of dyspareunia (pain with intercourse), dyschezia (pain with bowel movements), 
or focal low back pain. All pelvic pain patients reported attempting at least one prior 
medical or surgical therapy and had persistent pelvic pain. Endometriosis without CPP was 
defined as the absence of any prior history of chronic pelvic pain and the absence of 
significant dysmenorrhea, defined as pelvic pain during menstruation rated as ≥ 4 on a 0–10 
numeric rating scale occurring for 5 or more days of each menstrual cycle (i.e. all study 
participants falling into the ⊕EndoØCPP group had at maximum 4 days of mild pain 
associated with menses).
Using the Complex Medical Symptom Inventory, a standardized diagnostic tool that uses 
published criteria for the diagnosis of various chronic pain disorders70, all women with 
endometriosis and/or CPP were formally evaluated and excluded from participation if they 
had symptoms consistent with one or more of the following chronic pain syndromes: 
fibromyalgia, chronic fatigue syndrome, interstitial cystitis, vulvodynia, chronic low back 
pain unrelated to pelvic pain, or temporomandibular disorder. Although comorbid pain 
conditions are common among women with endometriosis or chronic pelvic pain, we wished 
to determine whether differences in neuroimaging parameters were identified specifically in 
women whose primary pain symptom was thought to be secondary to endometriosis, and not 
secondary to the presence of the above comorbid pain syndromes, which are are known to 
be associated with CNS changes in pain processing. However, we did not specifically 
exclude irritable bowel syndrome or migraine headache from our endometriosis or pelvic 
groups due to the difficulty in recruiting patients without these 2 commonly comorbid pain 
conditions. However, there was no significant difference in the distribution of these 
conditions across the endometriosis and CPP samples.
All healthy controls were pain-free women age 18–52 years and had no symptoms of 
dysmenorrhea, no known history of endometriosis, no history of chronic pain (including 
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pelvic pain), and did not have prior hysterectomy or bilateral oophorectomy. All healthy 
controls were formally screened in a similar fashion to endometriosis participants, did not 
meet criteria for any of the chronic pain syndromes previously defined, and did not have a 
history of chronic, recurrent headaches or irritable bowel syndrome (IBS). Women with 
current symptoms of major depressive disorder, bipolar disorder, generalized anxiety 
disorder (according to Diagnostic and Statistical Manual of the American Psychiatric 
Association IV1 criteria) 1 and those currently on antidepressants for any indication were 
also not eligible for participation as a healthy control.
Additional exclusion criteria for all participants included severe physical impairment, 
significant comorbid medical illness that limited physical function, and suicide attempt or 
substance abuse within 2 years of the study. Women who were pregnant, lactating, or 
menopausal (defined as no menses for greater than one year unrelated to exogenous 
hormonal suppression) were also excluded from participation. All participants had to be free 
of contraindications for an MRI study as determined by a health questionnaire and were 
right-handed to simplify brain mapping.
This study also included exploratory data on six participants with CPP but no evidence of 
endometriosis (ØEndo⊕CPP). These women fulfilled all clinical criteria of CPP, had 
undergone a diagnostic laparoscopy within 3 years of study participation and had no surgical 
evidence of endometriosis or pelvic adhesions at the time of any prior surgical exploration. 
No other anatomic sources of pain, such as uterine fibroids or ovarian masses, were 
identified in these patients. The same additional inclusion and exclusion criteria were 
applied to this subgroup. Given the smaller sample of ØEndo⊕CPP subgroup [n=6], 2 
controls were selected to match each ØEndo⊕CPP participant.
Assessment and analysis of clinical characteristics
All participants completed standardized case report forms to assess their medical history, 
surgical history, medication use, and any pain symptoms. Participants with endometriosis or 
CPP completed additional standardized case report forms to assess the severity, pattern, and 
characteristics of their pelvic pain, as well as validated measures of anxiety and depression. 
Measurements included numeric ratings (0–10) of pelvic pain during their menses, and the 
average pain intensity and pain-related disability (“pain interference”) in the last week using 
the Brief Pain Inventory short-form (BPI-SF).17 The BPI-SF is a self-administered 
questionnaire that provides 2 summary measures of pain experience: 1) subjective rating of 
pain intensity and (BPI Severity, range 0–10) and 2) pain interference (BPI Interference, 
range 0–10) which is defined as the degree to which a subject reports functional and 
activity-related disability attributed to pain. Higher scores indicate more severe pain 
intensity and pain interference. Anxiety and depression were measured using the 20-item 
Trait Anxiety and Trait Depression subscales from the State-Trait Personality Inventory 
(STPI).60 Scores for each subscale range from 10 to 40, with higher values indicating greater 
symptoms of anxiety or depression.
Participants with endometriosis or chronic pelvic pain signed medical release forms to 
obtain operative reports from their most recent pelvic surgery. Each report was reviewed by 
one of the authors [SA] with significant experience in the surgical evaluation of 
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endometriosis and other gynecologic disease. This author was blinded to the remainder of 
the study results, and endometriosis was assigned a stage according to the revised American 
Fertility Society endometriosis scoring system (rAFS).2 Surgical pathology was documented 
when available but not required for participation since pathologic confirmation was not 
routinely performed in all participants.
All continuous variables were evaluated for normality. Categorical data were compared 
using Pearson’s Chi-squared test or Fisher’s exact test. Comparison of continuous variables 
was conducted using analysis of variance or independent-samples t-test for parametric data 
or Kruskal-Wallis test for non-parametric data, as appropriate. Proportions, means (standard 
deviation), medians (range) were presented, as appropriate. The significance threshold was 
set at p<0.05.
Neuroimaging scanning protocol and analysis
In order to minimize the influence of menstrual cycle variability on study results, all study 
visits were performed between days 2–10 of the menstrual cycle in women who were not 
using hormonal contraceptives. Women who were using hormonal contraceptives were 
scheduled on any day that they were taking an active hormone medication. There was no 
significant difference in current use of hormonal contraceptive across study groups (p=0.37). 
Magnetic resonance imaging was performed on a 3.0 Tesla MR scanner (General Electric 
Medical Systems Signa, Milwaukee, WI). For each subject, a T-1 weighted gradient echo 
data set (TR/TE=1400/5.5 ms, flip angle=20°, FOV=256×256, yielding 124 sagittal slices 
with a defined voxel size of 1×1×1.2mm) was acquired. An Eclipse 3.0 T 94 quadrature 
head coil was used. Inspection of individual T1 MR-images revealed no gross 
morphological abnormality for any participant.
Acquisition and analysis of proton magnetic resonance spectroscopy
Proton magnetic resonance spectroscopy (1H-MRS), which provides a non-invasive method 
for the in-vivo study of brain biochemistry and allows measures of chemical concentrations 
in local brain regions of interest, was used to measure right anterior and posterior insula 
concentrations of N-acetylaspartate (NAA) and combined glutamate and glutamine (Glx). 
Since glutamate and glutamine share highly similar structures and have overlapping 
chemical shifts on spectroscopy, we cannot report individual glutamate or glutamine signals 
and only report the combined signal that comes from both molecules. Single-voxel proton 
magnetic resonance spectroscopy (1H-MRS) was performed using the following parameters 
as previously described by our group33: point resolved spectroscopy, TR/TE=3,000/3 msec, 
flip angle=90°, number of excitations 8, field of view 16 cm, with a volume of interest 
(VOIC) of 2 × 2 × 3 cm. Participants were at rest during the 1H-MRS session. During each 
session, 2 separate single-voxel spectroscopy sequences were performed, once with the VOI 
placed in the right anterior insula and once in the right posterior insula (Figure 1A). The 
approximate Montreal Neurological Institute coordinates for the centers of the right anterior 
and right posterior voxels were 34,19,0 and 38,−17,8, respectively. These coordinates were 
specifically chosen as the primary area of interest since these include regions shown 
previously to be activated during acute pain13, and have been shown to have augmented pain 
activity in patients with fibromyalgia.18, 28
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The raw data from each single-voxel MR spectroscopy sequence underwent manual post-
processing using dedicated 1H-MRS software (LCModel; Stephen Provencher, Oakville, 
Ontario, Canada). LCModel uses a linear combination of individual spectra obtained from 
pure molecular species to fit the experimental spectra (Figure 1B). Values for combined 
glutamate and glutamine (Glx) and NAA were calculated as absolute concentrations using 
the water signal for normalization.55 Resulting metabolite absolute concentrations were 
reported in arbitrary institutional units. Metabolite levels were corrected for cerebrospinal 
fluid (CSF) volume in each participant since spectroscopy voxels include CSF, and the 
volume of CSF dilutes 1H-MRS derived metabolite values. Voxel Based Morphometry, a 
tool box that operates within the image analysis program Statistical Parametric Mapping 
(SPM; http://www.fil.ion.ucl.ac.uk/spm/software), was used to correct metabolite levels for 
CSF volume. High resolution T1-weighted images were segmented into gray matter, white 
matter, and CSF. Regions of interest within the anterior and posterior insula were used to 
extract gray matter, whiter matter, and CSF volumes from these images using the SPM2 
toolbox Marsbar (http://marsbar.sourceforge.net).12 Metabolite values were corrected by 
dividing the observed concentration in arbitrary institutional units by the percentage of 
volume of the entire voxel that was not occupied by CSF (i.e. the percentage of voxel 
volume occupied by gray matter plus white matter). Corrected metabolite concentrations 
were entered into SPSS version 16 (SPSS, Chicago, IL) for calculation of difference 
between patient subgroups and healthy controls groups and for correlational analyses with 
clinical measures. Independent-samples t-tests and spearman’s correlational analyses were 
used. Significant correlations were defined as p < 0.05.
Acquisition and analysis of resting-state functional connectivity
Six minutes of resting-state fMRI data were acquired using a whole brain T2*-weighted 
gradient echo BOLD EPI pulse sequence (TR/TE=2000/30 ms, flip angle=90°, 43 AC-PC 
aligned axial slices, voxel size=3.125×3.125×4 mm). Subjects were instructed to relax and 
lie still with their eyes open during the functional MRI scan. A fixation cross was presented 
on the screen and subjects were told to lie still and fixate on the cross throughout the scan. 
Minimal cognitive tasks such as staring at a cross typically do not disrupt resting-state 
networks. Physiological data were collected simultaneously to the fMRI scan to correct 
cardiorespiratory fluctuations influence on fMRI functional connectivity estimation. Cardiac 
data were acquired using an infrared pulse oximeter (GE) attached to the right middle finger. 
Respiratory volume data were acquired using a GE MR- compatible belt placed around the 
subject’s abdomen. Participants’ motion was minimized using foam pads placed around the 
head along with a forehead strap.
Functional MRI data were pre-processed using the validated FSL (FMRIB’s Software 
Library, http://www.fmrib.ox.ac.uk/fsl), AFNI (afni.nimh.nih.gov/afni, and FreeSurfer 
(http://surfer.nmr.mgh.harvard.edu) software packages. Data were corrected for 
physiological artifacts (RETROICOR, AFNI27), slice timing, affine head motion 
(MCFLIRT, FSL40). Non-brain regions were removed from the image (BET, FSL59). 
Cortical surface reconstruction was completed to perform improved structural-functional co-
registration using FreeSurfer’s bbregister tool30. Functional data were then registered to 
standard Montreal Neurological Institute (MNI) space using FMRIB’s nonlinear co-
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registration tool (FNIRT, FSL). Data were resampled to 2-mm isotropic voxels and spatially 
smoothed using a 6-mm FWHM Gaussian kernel. High-pass temporal filtering was applied 
at 0.008Hz.
Functional connectivity was computed using a seed-based correlation analysis.9, 26, 29, 46 
The seed region was defined in the right anterior insula using the same regions evaluated 
with 1H-MRS. The anterior insula was chosen since this region was found to have elevated 
excitatory metabolite concentrations relative to healthy controls. The timeseries signals were 
extracted and averaged from the seed region, and then used as a regressor in a general linear 
model. Nuisance regressors were included in this model to control for any residual shared 
variance with non-neuronal signals: the six translation and rotation parameters of the rigid 
body head motion correction step, fMRI timeseries signals averaged over regions centered in 
the deep cerebral white matter, cerebral ventricles, and cardiorespiratory artifacts defined by 
convolving the heart rate and respiratory variation timeseries with appropriate cardiac and 
respiratory transfer functions, as defined by Chang and colleagues15 and Birn and 
colleagues8. We did not include the global signal in this analysis. Seed correlation maps, and 
their variance, were passed up to group level analyses. Such analyses contrast connectivity 
between different subgroups of endometriosis/CPP patients and age-matched healthy 
controls, using FLAME (FMRIB’s Local Analysis of Mixed Effects, FSL).
Given the elevated concentrations of excitatory neurotransmitters in the anterior insula of 
the endometriosis with CPP subgroup, we also performed whole brain voxel-wise linear 
regression analysis to investigate the link between functional connectivity and levels of 
excitatory neurotransmitters in the seed regions (anterior and posterior insula), as well as 
clinical measures of pain and mood. In this analysis, CSF-adjusted levels of excitatory 
neurotransmitters, BPI pain intensity, STPIDA-A, and SPTIDA-A were used as the 
independent variables and functional connectivity data (seed correlation and variance maps) 
were used as the dependent variables. Functional connectivity values (z-statistic) were 
extracted from the peak voxel, rather than all voxels of the ROI, since peak voxels have 
previously been demonstrated to have stronger correlation with synaptic activity.4 All brain 
maps were thresholded using the standard FSL toolbox cluster correction for multiple 
comparisons. The FSL cluster-forming threshold of Z>2.3 and a cluster-size threshold of 
p<0.05 to control for familywise error (FWE) is considered widely acceptable and accounts 
for multiple comparisons.
Ethical approval
Approval for this study was obtained from the University of Michigan Institutional Review 
Board. All participants provided informed, signed consent prior to participation in the study 
protocol.
Results
Clinical and demographic characteristics of participant subgroups
The surgical history and clinical characteristics of patients with endometriosis or pelvic pain 
are presented in Table 1. Participants with CPP (⊕Endo⊕CPP and ØEndo⊕CPP subgroups) 
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reported similar and clinically severe pain intensity scores, with high average pain intensity 
in the past month and during their menses. There was no significant difference in average 
duration of pelvic pain symptoms, number of pelvic pain days per month, or pain intensity 
before or during menses when comparing these two pelvic pain subgroups (p>0.30 for all 
comparisons). The ⊕EndoØCPP actually had more advanced-stage endometriosis than the 
⊕Endo⊕CPP group, but there was no correlation between endometriosis stage and any other 
clinical pain characteristic. There was no difference in proportion of women who were 
currently using a method of hormonal contraceptive (Table 1). There was also no difference 
in proportion of healthy controls currently using hormonal contraceptives as compared to 
those with endometriosis and/or CPP (p=0.37).
Proton Resonance Spectroscopy of the anterior and posterior insula in subjects with 
endometriosis with and without chronic pelvic pain compared with healthy controls
1H-MRS values were not available for two subjects in the ⊕Endo⊕CPP group due to poor 
quality spectra. As shown in Table 2 and Figure 2, ⊕Endo⊕CPP participants displayed 
elevated levels of Glx within the anterior insula relative to their age-matched healthy 
controls. When examining anterior insula metabolite to creatine ratios, participants with 
⊕Endo⊕CPP also demonstrated elevated Glx/Cr and reduced NAA/Cr ratios. There were no 
significant differences in posterior insula metabolite concentrations or metabolite/Cr ratios 
in the ⊕Endo⊕CPP when compared to age-matched healthy controls. Unlike participants 
with CPP, endometriosis without CPP participants (⊕EndoØCPP) did not demonstrate any 
difference in any of the anterior or posterior insula metabolite concentrations or creatine 
ratios when compared to their age-matched controls.
Linear regression was used to calculate residual values of metabolite concentrations after 
adjusting for age. Spearman correlational analysis was then performed to evaluate the 
relationship between age-adjusted metabolite concentrations, clinical pain intensity, 
depression, and anxiety within each of the endometriosis patient subgroups. Among 
participants with endometriosis and chronic pelvic pain (⊕Endo⊕CPP), there was no 
statistically significant correlation (defined as p<0.05) between any anterior or posterior 
insula metabolite concentrations and measures of anxiety, depression, BPI pain intensity, or 
BPI pain interference. Similarly, there was no significant correlation between anterior or 
posterior insula metabolite concentrations and anxiety, depression, or pain measures among 
participants with endometriosis without CPP (⊕EndoØCPP).
Intrinsic brain connectivity in subjects with endometriosis with and without chronic pelvic 
pain compared with healthy controls
Resting functional connectivity was examined in 16 ⊕Endo⊕CPP participants (data was 
incomplete in 1 participant) and all 13 ⊕EndoØCPP participants. Since we observed 
increased Glx within the anterior insula of ⊕Endo⊕CPP subjects, we used this 1H-MRS 
voxel as a seed in resting connectivity MRI. When comparing ⊕Endo⊕CPP subjects to age-
matched controls, greater connectivity was identified between the anterior insula and regions 
of the medial prefrontal cortex (mPFC), as well as the occipital cortex (Figure 3, Table 3). 
We did not identify any brain regions with altered connectivity to the posterior insula when 
comparing ⊕Endo⊕CPP subjects to age-matched controls.
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Resting functional connectivity was also compared in ⊕EndoØCPP subjects versus age-
matched healthy controls. In contrast to endometriosis subjects with CPP, we did not 
identify any brain regions with altered connectivity to the anterior or posterior insula in the 
endometriosis subjects without CPP.
Correlations between spectroscopy and functional connectivity in subjects with 
endometriosis and chronic pelvic pain (⊕Endo⊕CPP)
Given the finding of increased connectivity between the anterior insula and medial 
prefrontal cortex in the ⊕Endo⊕CPP subgroup compared to age-matched controls, we then 
sought to determine if resting functional connectivity of the anterior insula was correlated 
with the anterior insula Glx. Whole brain linear regression analysis was performed in 14 
⊕Endo⊕CPP subjects who had both 1H-MRS and intrinsic connectivity data and found 
positive correlation between Glx metabolite concentrations in the anterior insula and resting 
anterior insula connectivity to the mPFC (r=0.87) (Table 4, Figure 4).
We then performed ROI correlation analysis between resting anterior insula connectivity to 
mPFC and clinical measures of pain and mood in the ⊕Endo⊕CPP group. Functional 
connectivity values (z statistics) were extracted from the peak voxel of dorsomedial 
prefrontal cortex (from the whole brain regression result, Table 4). We found that greater 
anterior insula connectivity to mPFC was significantly correlated with anxiety scores 
(STPIDA-A, r(12)=0.61, p=0.02), depression scores (STPIDA-D, r(12)=0.60, p=0.03), as 
well as clinical pain intensity (BPI, r(11)=0.55, p=0.05) (Figure 5).
Exploratory analysis in patients with chronic pelvic pain without endometriosis compared 
with healthy controls
Participants with ØEndo⊕CPP [n=6] showed a significant increase in Glx concentrations in 
the anterior insula, as well as reduced NAA/Cr ratios in this region as compared to age-
matched healthy controls. There were no significant differences in posterior insula 
metabolite concentrations or metabolite/Cr ratios in this subgroup, except for decreased 
NAA concentrations in the posterior insula (Table 2). These findings are thematically 
similar to those seen in the ⊕Endo⊕CPP versus healthy controls analysis. Given the small 
sample size of n=6, correlational analysis with age-adjusted metabolite concentrations and 
clinical variables was not performed. Resting functional connectivity was also examined in 
these six ØEndo⊕CPP participants. We did not identify any brain regions with altered 
connectivity to the insula when comparing ⊕Endo⊕CPP subjects and age-matched healthy 
controls.
Discussion
Consistent with our hypothesis, women with endometriosis-associated CPP demonstrate 
increased concentrations of excitatory neurotransmitters in the anterior insula and had 
greater intrinsic connectivity of the same anterior insula region to the mPFC, both known to 
be regions important in pain processing. Furthermore, increased connectivity between these 
two regions was positively correlated with anterior insula Glx concentrations, as well as 
with pain intensity, anxiety and depression symptom severity. These findings are 
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thematically similar to those in other centralized pain states, including fibromyalgia and 
IBS.32, 37, 39, 51, 52 The CPP patients without endometriosis showed similar findings of 
elevated excitatory neurotransmitters in the anterior insula, while the endometriosis patients 
without CPP showed no evidence of changes in insular metabolite levels or resting 
connectivity relative to pain-free controls, suggesting these alterations in brain physiology 
may be specific to the pelvic pain state, rather than simply from endometriosis.
Increased excitatory neurotransmitter levels in the anterior insula
The role of the glutamergic system in the neurobiology of chronic pain is an area of active 
investigation. Glutamate is the brain’s primary excitatory neurotransmitter. Astrocystes 
transform glutamate to glutamine, which serves as a precursor to both glutamate and γ-
aminobutyric acid (GABA), the primary inhibitory neurotransmitter. Using 1H-MRS, we 
previously reported increased levels of posterior insula Glx in fibromyalgia patients33 and 
have shown that longitudinal reduction in pain scores were associated with parallel 
reductions in posterior insula Glx.34 Moreover, pregabalin, with demonstrated efficacy in 
fibromyalgia and neuropathic pain, is associated with a reduction in posterior insula Glx.32 
In line with this work, these results support the notion that increased activity of the insula is 
an underlying mechanism of endometrisois-associated CPP and future studies are warranted 
to investigate whether pharmacologic therapy can effectively reduce insular glutamate levels 
and treat chronic pelvic pain.
Although these findings are thematically similar to findings in fibromyalgia, it is noteworthy 
that the main 1H-MRS results in CPP are in the anterior, not posterior insula. The reason for 
the difference is unknown, and several possible explanations underscore the concept that 
dysfunction in different mechanistic pathways can lead to the same clinical consequence of 
central pain amplification. The insula has long been recognized to be a multidimensional 
region that participates in somatic and visceral sensory processing.65 The posterior division 
plays a prominent role in pain and interoceptive processing, and its activity correlates with 
linear changes in stimulus intensity.3, 20, 48 In contrast, the anterior insula is involved in the 
evaluative processing of pain and emotional awareness19, 69, and is active when pain is 
perceived, even when no innocuous stimulus is present.22 While these topographic 
differences are often assigned distinctly, evidence suggests that there is significant overlap 
and integration of neural signals related to both pain and mood. While sensory information 
is mapped to the posterior insula, it is re-represented in the anterior insula, with significant 
overlap of pain, emotion, and sensorimotor response.50 Pain signals become consciously 
accessible in the anterior insula, enabling the affective experience of pain. Furthermore, 
regions involved in such pathways may shift in disease states, which may explain the 
significant comorbidity of pain, depression and “emotional allodynia”-the concept that 
individuals with major depression report pain to stimuli that are not considered painful.
Although prior work from our group did not identify differences in excitatory 
neurotransmitter metabolites in the anterior insula of patients with fibromyalgia33, we have 
demonstrated lower levels of GABA, the primary inhibitory neurotransmitter, in the right 
anterior insula.25 Thus, while the molecular underpinnings may not be the same in CPP and 
fibromyalgia patients, both chronic pain populations demonstrate “over-activity” of the 
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anterior insula, the former group due to elevated excitatory neurotransmitters and the latter 
due to decreased inhibitory neurotransmitters.
Increased connectivity of the anterior insula and the default mode network
In addition to differences in neurotransmitter activity, accumulating evidence also suggests 
that altered intrinsic brain connectivity is a pathologic factor in the mechanism of chronic 
pain. One particular area of focus is altered connectivity between the anterior insula, a key 
region of the salience network, and the default mode network (DMN).10 Recently, a three 
dimensional model has been proposed in which the salience network, involved in the 
integration of internal and external signals to identify salient stimuli, mediates the switching 
between activation of the DMN and the central executive network (CEN).49, 65 The DMN is 
thought to support self-referential and internally related cognition, while the CEN supports 
goal-oriented or externally-directed cognition. Resting insula connectivity to areas of the 
DMN is augmented in patients with fibromyalgia51, 52, IBS37, and chronic low back pain44. 
Moreover, reductions in clinical pain after treatment with pregabalin32 and acupuncture51 
were both associated with reduced insular Glx and reduced resting connectivity between the 
insula and regions of the DMN. Our findings in endometriosis-associated CPP patients 
suggest a similar underlying mechanism of pain, since we also demonstrate similar increases 
in connectivity between the insula and mPFC, a key component of the DMN. One may 
speculate that patients with chronic pain may have impaired ability to disengage from 
internal stimuli due to increased connectivity between regions of the salience network and 
DMN.
Endometriosis and CPP – growing evidence supports a central pain disorder
Our findings add to the growing body of literature, recently summarized by Brawn11, that 
dysfunction in the CNS pain regulatory system may play a role in the underlying mechanism 
of endometriosis-associated CPP. For example, our group found that women with CPP 
exhibit hyperalgesia at a non-pelvic site, which was independent of the presence and 
severity of endometriosis or the presence or number of comorbid pain disorders.5 We have 
also demonstrated decreased gray matter volume (GMV) in key pain regulatory regions such 
as the thalamus, cingulate gyrus, putamen and insula in women with CPP, with and without 
endometriosis.6 Among those with endometriosis-associated CPP, decreases in GMV in the 
thalamus, mid-cingulate cortex, and posterior insula negatively correlated with pain 
unpleasantness. Furthermore, endometriosis without CPP did not exhibit hyperalgesia or 
changes in regional GMV, but did demonstrate increased GMV in the periaqueductal gray 
(PAG), a key structure in the endogenous, antinociceptive pain regulatory system. Thus, it is 
possible that endometriosis without CPP patients experience little if any pelvic pain due to 
adaptive, antinociceptive activity. Our findings and others suggest that each person’s clinical 
pain experience is likely determined by a complex interaction between peripheral factors 
(e.g. endometriosis), anti-nociceptive capacity (e.g. activity of the PAG), and maladaptive 
changes in the CNS pain regulatory system. A growing body of literature also suggests that 
even among visceral CPP conditions such as endometriosis and painful bladder syndrome, 
pelvic pain is often associated with alterations in the mechanical sensitivity of the pelvic 
floor musculature36, 63, 64 and altered muscle activity in chronic pain may be related to 
changes in motor cortical structure and function.42 Genetic factors, environmental stressors, 
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and cognitive/behavioral factors likely modulate chronic pain14, 23, and all these factors 
deserve further investigation in women with endometriosis-associated CPP.
Strengths and limitations
Strengths of this study include the use of patient subgroups with various combinations of 
pain severity and pelvic pathology, the prospective collection of data regarding clinical pain 
and mood, and the systematic exclusion of patients with several comorbid pain syndromes 
using standardized criteria. While positive correlation between intrinsic connectivity and 
glutamate concentrations has been demonstrated in previous studies using healthy 
controls24, 41, this is the first study to our knowledge to use multimodal imaging to 
demonstrate a correlation between Glu and increased connectivity of the insula to areas of 
the DMN in a chronic pain condition. These findings and others point to the important 
interplay of neurotransmitter balances and inter-regional brain networks on health and 
disease.
Although our small sample size limited our ability to disentangle the complex and 
commonly co-occurring relationship between pain and mood, our findings support prior 
work that suggests the anterior insula plays a role in both pain and mood.50, 58 Larger 
samples that include chronic pain patients with and without mood disorders are needed to 
better differentiate the independent effects of mood and pain. Our sample of endometriosis 
and CPP patients were recruited through a tertiary care clinic and may not be generalizable 
to community samples. The cross-sectional design of this study also precludes our ability to 
determine whether the neuroimaging changes are a cause or consequence of chronic pain. 
Longitudinal studies are needed to address this important question. We also did not include 
CPP or endometriosis patients who experienced improvement in pain following therapy and 
therefore cannot comment on how this group may be similar or different than those who 
have asymptomatic endometriosis or those whose pain is unresponsive to usual therapy. 
Furthermore, the endometriosis and pelvic pain subgroups (⊕Endo⊕CPP, ØEndo⊕CPP, and 
⊕EndoØCPP) were not directly compared to each other because of the significant age 
difference between the ⊕Endo⊕CPP and ⊕EndoØCPP groups and the small sample in the 
ØEndo⊕CPP group. While we have postulated that the ⊕Endo⊕CPP subjects are likely 
different than the ⊕EndoØCPP group (since the findings in the ⊕Endo⊕CPP group were 
robust and no findings were identified in the ⊕EndoØCPP), future studies should recruit 
adequate age-matched subjects that can directly compare these patient subgroups. Also, not 
all controls underwent prior surgery to exclude the diagnosis of asymptomatic 
endometriosis. However, given a 0.07–11% prevalence of endometriosis in asymptomatic 
women53, we would not expect this to significantly influence our results. Finally, the 
ØEndo⊕CPP subgroup was very small due to challenges recruiting eligible participants in 
our referral setting that primarily sees endometriosis patients, and this analysis was 
considered exploratory. Although we did identify similar differences in anterior insula 
metabolite levels in this subgroup, we did not identify any differences intrinsic brain 
connectivity. While this sample is likely underpowered to detect this difference if it exists, 
larger samples that directly compare all subgroups to each other are needed to determine if 
these central changes are specific to the pelvic pain state, or unique to endometriosis-
associated CPP.
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Conclusion
In summary, these findings add to the growing body of literature that suggests that, in at 
least some with women with CPP, pelvic pain is not sufficiently explained by the presence 
of endometriosis and may be due to dysfunction in the CNS pain regulatory system. These 
findings have important implications for the evaluation and management of women with 
CPP and may explain why some of these women do not respond to therapies aimed at 
eliminating endometriosis. Almost certainly, CPP patients represent highly heterogeneous 
subgroups that have variable degrees of peripheral and central contributions to pain 
symptoms. For example, it may be that some women will benefit more from pharmacologic 
and cognitive therapies aimed at central pain amplification and could avoid repetitive 
surgeries directed at pelvic pathology. Identification of these subgroups likely represents a 
critical step in the development of a personalized, mechanism-based approach for 
individuals with CPP.
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Perspective
Similar to other chronic pain conditions, endometriosis-associated pelvic pain is 
associated with altered brain chemistry and function in the pain matrix. These findings 
support central pain amplification as a mechanism of CPP, and clinicians should consider 
the use of adjunctive therapies that target central pain dysfunction in these women.
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Highlights
• Chronic pelvic pain is a symptom in some, but not all women with 
endometriosis
• The mechanism by which only some women with endometriosis experience pain 
is not understood
• Endometriosis-associated pelvic pain is associated with altered brain chemistry 
and function
• These differences were not identified in a pain-free endometriosis subgroup
• Central nervous system changes likely contribute to the mechanism of 
endometriosis pain
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Figure 1. 
Anterior and posterior insula regions of interest (ROIs) and resulting spectrum. A. Sagittal 
T1- weighted images showing single-voxel placement for right anterior insula (ant) and right 
posterior insula (post). B. Representative proton magnetic resonance spectroscopy spectrum 
from the posterior insula fit with LCModel (red trace; * = resonance from 2 glutamate 
proton resonances at 2.35 parts per million). LCModel uses linear combination of individual 
spectra obtained from pure molecular species to fit the experimental spectra. Absolute 
concentrations of Glx (glutamine and glutamate) and NAA were calculated in arbitrary units 
using water as an internal scaling factor.
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Figure 2. 
Combined glutamine and glutamate (Glx) levels are elevated within the anterior insula in 
women with chronic pelvic pain (CPP), regardless of endometriosis status.
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Figure 3. 
Greater connectivity between anterior insula and medial prefrontal cortex (mPFC) in women 
with endometriosis and chronic pelvic pain (⊕Endo⊕CPP, n=16).
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Figure 4. 
Anterior insula connectivity to medial prefrontal cortex (mPFC) is correlated with Glx levels 
in anterior insula in women with endometriosis and chronic pelvic pain (⊕Endo⊕CPP, 
n=14), p<0.05.
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Figure 5. 
Anterior insula connectivity to medial prefrontal cortex (mPFC) is correlated with anxiety 
(STPIDA-A), depression (STPIDA-D), and pain intensity (BPI) scores in women with 
endometriosis and chronic pelvic pain (⊕Endo⊕CPP, n=14).
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